1. Does angiotensin receptor blockade improve outcomes in patients with heart failure and preserved ejection fraction? Results of the I-PRESERVE study

   • Henry Krum

   Clinical Trials Report 31 May 2009 Pages: 65 - 67

2. Nitric oxide regulation of autonomic function in heart failure

   • Harold D. Schultz

   OriginalPaper 31 May 2009 Pages: 71 - 80

3. The brain renin-angiotensin-aldosterone system: A major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction

   • Bing S. Huang
   • Frans H. H. Leenen

   OriginalPaper 31 May 2009 Pages: 81 - 88

4. Insulin resistance and heart failure

   • Patrick M. Heck
   • David P. Dutka

   OriginalPaper 31 May 2009 Pages: 89 - 94

5. Respiratory muscle function and exercise intolerance in heart failure

   • Jorge P. Ribeiro
   • Gaspar R. Chiappa
   • Lutz Frankenstein

   OriginalPaper 31 May 2009 Pages: 95 - 101

6. Pharmacologic management of the cardiorenal syndrome in heart failure

   • Henry Krum
   • Pupalan Iyngkaran
   • Suree Lekawanvijit

   OriginalPaper 31 May 2009 Pages: 105 - 111

7. Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: How much is too much?

   • Bertram Pitt

   OriginalPaper 31 May 2009 Pages: 112 - 116

8. Should aldosterone blockade be used beyond current indications in heart failure?

   • Marcelle D. Smit
   • Isabelle C. van Gelder
   • Dirk J. van Veldhuisen

   OriginalPaper 31 May 2009 Pages: 117 - 125

9. Pharmacologic management of patients with both heart failure and diabetes

   • Michael R. MacDonald
   • Mark C. Petrie
   • John J. V. McMurray

   OriginalPaper 31 May 2009 Pages: 126 - 132